Antifungal Drugs Market By Drug Class (Azoles, Polyenes, Allylamines, Echinocandins, Pyrimidines, Others), By Infection Type (Aspergillosis, Dermatophytosis, Candidiasis, Cryptococcosis, Mucormycosis, Others), By Route of Administration (Oral, Topical, Parenteral), By Dosage Form (Tablets, Capsules, Ointments & Creams, Powders, Suspensions, Injections), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics), By End User (Hospitals, Clinics, Homecare, Research & Academic Institutes), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

Report Coverage:

By Drug Class

• Azoles
• Polyenes
• Allylamines
• Echinocandins
• Pyrimidines
• Others

By Infection Type

• Aspergillosis
• Dermatophytosis
• Candidiasis
• Cryptococcosis
• Mucormycosis
• Others

By Route of Administration

• Oral
• Topical
• Parenteral

By Dosage Form

• Tablets
• Capsules
• Ointments & Creams
• Powders
• Suspensions
• Injections

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Specialty Clinics

By End User

• Hospitals
• Clinics
• Homecare
• Research & Academic Institutes

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Pfizer Inc.
• Merck & Co., Inc.
• Novartis AG
• Sanofi S.A.
• GlaxoSmithKline plc (GSK)
• Bayer AG
• Astellas Pharma Inc.
• Abbott Laboratories
• Johnson & Johnson
• Roche Holding AG
• Gilead Sciences, Inc.
• Eli Lilly and Company
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.